<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02451670</url>
  </required_header>
  <id_info>
    <org_study_id>A13-154</org_study_id>
    <secondary_id>U19MH092201</secondary_id>
    <nct_id>NCT02451670</nct_id>
  </id_info>
  <brief_title>Reducing Cardiovascular Risk in Adults With Serious Mental Illness</brief_title>
  <acronym>SMIWizard</acronym>
  <official_title>Reducing Cardiovascular Risk in Adults With Serious Mental Illness Using an Electronic Medical Record-based Clinical Decision Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Essentia Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Park Nicollet Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This purpose of this study is to adapt, implement and test the ability of a sophisticated
      point-of-care electronic health record-based clinical decision support that identifies and
      prioritizes all available evidence-based treatment options to reduce cardiovascular risk in
      patients with serious mental illness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study adapted a point-of-care electronic health record-based clinical decision support
      system (The Cardiovascular Wizard) to help primary care providers identify, provide
      appropriate care for, and control cardiovascular risk factors for patients with serious
      mental illness (bipolar disorder, schizophrenia, schizo-affective disorder). The
      Cardiovascular Wizard is designed to educate primary care providers about the increased risk
      of cardiovascular disease and mortality in people with serious mental illness, identify
      elevated cardiovascular risk factors in patients with serious mental illness, identify
      elevated cardiovascular risk factors in patients with serious mental illness, prioritize
      these cardiovascular risk based on how much improvement in cardiovascular risk a patient
      would experience if the cardiovascular risk factor was adequately addressed, recommend
      specific medications and other interventions to decrease each elevated cardiovascular risk
      factor, and provide this information in an easy-to-understand format for both patients with
      serious mental illness and their primary care providers.

      The Cardiovascular Wizard was printed in intervention clinics and (i) compiled lab data (most
      recent glycated hemoglobin, systolic blood pressure and low-density lipoprotein levels), body
      mass index, smoking status, and aspirin use, (ii) calculated a modifiable 10 year
      cardiovascular risk for stroke or heart attack using the American College of
      Cardiology/American Heart Association 10-year atherosclerotic cardiovascular disease risk
      equation, (iii) prioritized clinical domains based on the absolute risk reduction for each
      component, (iv) compiled information related to liver and renal function, creatinine kinase
      level, and previous diagnoses (Congestive Heart Failure, Cardiovascular Disease, Diabetes
      Mellitus, and (v) provided recommendations for intensification of therapy for glycated
      hemoglobin, systolic blood pressure, and/or low-density lipoproteins if not at goal.
      Recommendations were based on evidence-based protocols including Joint National Committee,
      American Diabetes Association, and the Institute for Clinical Systems Improvement.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2016</start_date>
  <completion_date type="Actual">September 19, 2018</completion_date>
  <primary_completion_date type="Actual">September 19, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Clinics have been randomized into a treatment and a control arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke</measure>
    <time_frame>Index to 12 months post index visit</time_frame>
    <description>A modifiable risk component for each cardiovascular risk factor not at optimal goal at the time of each encounter was calculated as the difference between total 10-year atherosclerotic cardiovascular disease risk with the patient's actual values and the goal value. Total modifiable cardiovascular risk was calculated by summing the modifiable cardiovascula risk components across cardiovascular risk factors not at optimal goal at the time of the encounter, and was calculated for each enrolled patient at the index visit and each subsequent encounter during the intervention period. Annual rate of change in modifiable cardiovascular risk was estimated from all patient encounters. A comparison of the difference in model-estimated rate of change in modifiable cardiovascular risk at 12 months post-index tested the primary efficacy hypothesis.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10347</enrollment>
  <condition>Chronic Disease</condition>
  <condition>Mental Disorder</condition>
  <condition>Health Behavior</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Prioritized Clinical Decision Support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving care in clinics randomized to the intervention arm of the study and their primary care providers were presented with patient-specific written advice as to prioritized treatment and lifestyle changes that could reduce their cardiovascular risk, prompted by an electronic health record-based alert during their primary care visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receiving care in clinics randomized to the usual care arm of the study and their providers were not presented with the prioritized clinical decision support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prioritized Clinical Decision Support</intervention_name>
    <description>After entry of blood pressure data at all primary care visits, relevant electronic health record data were automatically extracted, encrypted and processed through Web-based clinical algorithms that determined if the patient met intervention eligibility criteria. In intervention clinics, the rooming staff received a best practice alert and printed patient and primary care provider versions of the clinical decision support that identified evidence-based treatment options for any uncontrolled cardiovascular risk factors and prioritized treatment recommendations based on potential cardiovascular risk reduction. Cardiovascular risk factors addressed in study participants were control of lipids, blood pressure, weight, tobacco, glucose and appropriate aspirin use. In control clinics, rooming staff did not receive a best practice alert and patients and primary care providers did not receive and were not able to access the clinical decision support.</description>
    <arm_group_label>Prioritized Clinical Decision Support</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Serious Mental Illness diagnosis

          -  Age 18-75

          -  Index visit during the enrollment period

          -  First primary care visit where patient was not at goal for at least one of the six
             cardiovascular risk factor areas, and patient was not pregnant

          -  One or more post-index visits during the intervention period

        Exclusion Criteria:

          -  No Serious Mental Illness diagnosis

          -  Under age 18 or over age 75

          -  In hospice or nursing home

          -  At goal for all cardiovascular risk 6 areas

          -  On research exclusion list
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca C Rossom, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HealthPartners Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Essentia Health</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Nicollet Clinic</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthPartners</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011 Feb;23(1):40-7. Review.</citation>
    <PMID>21318195</PMID>
  </reference>
  <reference>
    <citation>Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. Arch Gen Psychiatry. 2007 Feb;64(2):242-9. Erratum in: Arch Gen Psychiatry. 2007 Jun;64(6):736.</citation>
    <PMID>17283292</PMID>
  </reference>
  <reference>
    <citation>De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009 Sep;24(6):412-24. doi: 10.1016/j.eurpsy.2009.01.005. Epub 2009 Aug 13.</citation>
    <PMID>19682863</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Crain AL, Rush WA, Sperl-Hillen JM, Gutenkauf JJ, Duncan JE. Impact of an electronic medical record on diabetes quality of care. Ann Fam Med. 2005 Jul-Aug;3(4):300-6.</citation>
    <PMID>16046561</PMID>
  </reference>
  <reference>
    <citation>Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000 Sep 29;45(1-2):21-8.</citation>
    <PMID>10978869</PMID>
  </reference>
  <reference>
    <citation>Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005 Dec;150(6):1115-21. Review.</citation>
    <PMID>16338246</PMID>
  </reference>
  <reference>
    <citation>Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999 Aug;187(8):496-502.</citation>
    <PMID>10463067</PMID>
  </reference>
  <reference>
    <citation>Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B. Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry. 2001 Apr;35(2):196-202.</citation>
    <PMID>11284901</PMID>
  </reference>
  <reference>
    <citation>Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001 Jun;58(6):565-72.</citation>
    <PMID>11386985</PMID>
  </reference>
  <reference>
    <citation>Trangle M, Gary M, Paul G, Christensen R. Minnesota 10 by 10. Reducing morbidity and mortality in people with serious mental illnesses. Minn Med. 2010 Jun;93(6):38-41.</citation>
    <PMID>20827954</PMID>
  </reference>
  <reference>
    <citation>Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 1;80(1):45-53. Epub 2005 Sep 28.</citation>
    <PMID>16198088</PMID>
  </reference>
  <reference>
    <citation>Newcomer JW. Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.</citation>
    <PMID>16965186</PMID>
  </reference>
  <reference>
    <citation>Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, Conigliaro J, Haas GL. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004 Oct;6(5):368-73.</citation>
    <PMID>15383128</PMID>
  </reference>
  <reference>
    <citation>Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007 Jun;68(6):917-23.</citation>
    <PMID>17592917</PMID>
  </reference>
  <reference>
    <citation>Wong CK, Tang EW, Herbison P, Birmingham B, Barclay L, Fu SY. Pre-existent depression in the 2 weeks before an acute coronary syndrome can be associated with delayed presentation of the heart attack. QJM. 2008 Feb;101(2):137-44. doi: 10.1093/qjmed/hcm153. Epub 2008 Jan 10.</citation>
    <PMID>18187481</PMID>
  </reference>
  <reference>
    <citation>Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68 Suppl 4:40-4.</citation>
    <PMID>17539699</PMID>
  </reference>
  <reference>
    <citation>Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009 Jul;66(7):713-20. doi: 10.1001/archgenpsychiatry.2009.61.</citation>
    <PMID>19581562</PMID>
  </reference>
  <reference>
    <citation>Mackin P, Bishop DR, Watkinson HM. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry. 2007 Jun 25;7:28.</citation>
    <PMID>17592636</PMID>
  </reference>
  <reference>
    <citation>Shah SU, White A, White S, Littler WA. Heart and mind: (1) relationship between cardiovascular and psychiatric conditions. Postgrad Med J. 2004 Dec;80(950):683-9. Review.</citation>
    <PMID>15579605</PMID>
  </reference>
  <reference>
    <citation>Sowden GL, Huffman JC. The impact of mental illness on cardiac outcomes: a review for the cardiologist. Int J Cardiol. 2009 Feb 6;132(1):30-7. doi: 10.1016/j.ijcard.2008.10.002. Epub 2008 Nov 11. Review.</citation>
    <PMID>19004512</PMID>
  </reference>
  <reference>
    <citation>Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: A review. J Clin Psychiatry. 2006 Jul;67(7):1034-41. Review.</citation>
    <PMID>16889445</PMID>
  </reference>
  <reference>
    <citation>Klumpers UM, Boom K, Janssen FM, Tulen JH, Loonen AJ. Cardiovascular risk factors in outpatients with bipolar disorder. Pharmacopsychiatry. 2004 Sep;37(5):211-6.</citation>
    <PMID>15470799</PMID>
  </reference>
  <reference>
    <citation>American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004 Feb;27(2):596-601. Review.</citation>
    <PMID>14747245</PMID>
  </reference>
  <reference>
    <citation>Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000 Jan 26;283(4):506-11.</citation>
    <PMID>10659877</PMID>
  </reference>
  <reference>
    <citation>Frayne SM, Halanych JH, Miller DR, Wang F, Lin H, Pogach L, Sharkansky EJ, Keane TM, Skinner KM, Rosen CS, Berlowitz DR. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005 Dec 12-26;165(22):2631-8.</citation>
    <PMID>16344421</PMID>
  </reference>
  <reference>
    <citation>Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry. 2002 Sep;159(9):1584-90.</citation>
    <PMID>12202281</PMID>
  </reference>
  <reference>
    <citation>Fagiolini A, Chengappa KN, Soreca I, Chang J. Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs. 2008;22(8):655-69. Review.</citation>
    <PMID>18601304</PMID>
  </reference>
  <reference>
    <citation>Mitchell JE, Mackenzie TB. Cardiac effects of lithium therapy in man: a review. J Clin Psychiatry. 1982 Feb;43(2):47-51.</citation>
    <PMID>7056703</PMID>
  </reference>
  <reference>
    <citation>Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001 Nov;158(11):1774-82. Review.</citation>
    <PMID>11691681</PMID>
  </reference>
  <reference>
    <citation>Morriss R, Mohammed FA. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol. 2005 Nov;19(6 Suppl):94-101. Review.</citation>
    <PMID>16280342</PMID>
  </reference>
  <reference>
    <citation>Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002 Apr;68(2-3):167-81.</citation>
    <PMID>12063145</PMID>
  </reference>
  <reference>
    <citation>Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002 Jun 7;71(3):239-57. Review.</citation>
    <PMID>12034344</PMID>
  </reference>
  <reference>
    <citation>Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005 Sep 22;353(12):1209-23. Epub 2005 Sep 19. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092-3.</citation>
    <PMID>16172203</PMID>
  </reference>
  <reference>
    <citation>Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ; PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med. 2006 Apr 4;144(7):485-95.</citation>
    <PMID>16585662</PMID>
  </reference>
  <reference>
    <citation>Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998 Mar 18;279(11):839-46. Erratum in: JAMA 1998 Jun 24;279(24):1954.</citation>
    <PMID>9515998</PMID>
  </reference>
  <reference>
    <citation>Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV 3rd, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013 Apr 25;368(17):1594-602. doi: 10.1056/NEJMoa1214530. Epub 2013 Mar 21.</citation>
    <PMID>23517118</PMID>
  </reference>
  <reference>
    <citation>Pylvänen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojärvi JI. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia. 2002 May;43(5):514-7.</citation>
    <PMID>12027912</PMID>
  </reference>
  <reference>
    <citation>Sachs G, Bowden C, Calabrese JR, Ketter T, Thompson T, White R, Bentley B. Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder. Bipolar Disord. 2006 Apr;8(2):175-81.</citation>
    <PMID>16542188</PMID>
  </reference>
  <reference>
    <citation>Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999 Nov;156(11):1686-96. Review.</citation>
    <PMID>10553730</PMID>
  </reference>
  <reference>
    <citation>Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, Kissling W, Leucht S. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006569. doi: 10.1002/14651858.CD006569.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006569.</citation>
    <PMID>19821375</PMID>
  </reference>
  <reference>
    <citation>Patel JK, Buckley PF, Woolson S, Hamer RM, McEvoy JP, Perkins DO, Lieberman JA; CAFE Investigators. Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res. 2009 Jun;111(1-3):9-16. doi: 10.1016/j.schres.2009.03.025. Epub 2009 Apr 26.</citation>
    <PMID>19398192</PMID>
  </reference>
  <reference>
    <citation>Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, Campbell E, Bates DW. Grand challenges in clinical decision support. J Biomed Inform. 2008 Apr;41(2):387-92. Epub 2007 Sep 21. Review.</citation>
    <PMID>18029232</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, Asche SE, Ekstrom HL, Gilmer TP. Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med. 2011 Jan-Feb;9(1):12-21. doi: 10.1370/afm.1196.</citation>
    <PMID>21242556</PMID>
  </reference>
  <reference>
    <citation>Leibson C, Owens T, O'Brien P, Waring S, Tangalos E, Hanson V, Plevak M, Kokmen E. Use of physician and acute care services by persons with and without Alzheimer's disease: a population-based comparison. J Am Geriatr Soc. 1999 Jul;47(7):864-9.</citation>
    <PMID>10404933</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Desai JR, Butler JC, Kharbanda EO, Sperl-Hillen JM. Current status and future prospects for electronic point-of-care clinical decision support in diabetes care. Curr Diab Rep. 2013 Apr;13(2):172-6. doi: 10.1007/s11892-012-0350-z.</citation>
    <PMID>23225213</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Quiter ES, Rush WA, Wiest M, Meland JT, Ryu S. Impact of hypertension guideline implementation on blood pressure control and drug use in primary care clinics. Jt Comm J Qual Improv. 1999 Feb;25(2):68-77.</citation>
    <PMID>10027112</PMID>
  </reference>
  <reference>
    <citation>Boyle RG, O'Connor PJ, Pronk NP, Tan A. Stages of change for physical activity, diet, and smoking among HMO members with chronic conditions. Am J Health Promot. 1998 Jan-Feb;12(3):170-5.</citation>
    <PMID>10176091</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Asche SE, Crain AL, Rush WA, Whitebird RR, Solberg LI, Sperl-Hillen JM. Is patient readiness to change a predictor of improved glycemic control? Diabetes Care. 2004 Oct;27(10):2325-9.</citation>
    <PMID>15451895</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Sperl-Hillen J. Clinical and public health implications of glycemic relapse in type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2007 Jan;3(1):10-1.</citation>
    <PMID>17179924</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ, Rush WA, Prochaska JO, Pronk NP, Boyle RG. Professional advice and readiness to change behavioral risk factors among members of a managed care organization. Am J Manag Care. 2001 Feb;7(2):125-30.</citation>
    <PMID>11216330</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ. Electronic medical records and diabetes care improvement: are we waiting for Godot? Diabetes Care. 2003 Mar;26(3):942-3. Review.</citation>
    <PMID>12610062</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2015</study_first_posted>
  <results_first_submitted>September 17, 2019</results_first_submitted>
  <results_first_submitted_qc>October 16, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 5, 2019</results_first_posted>
  <last_update_submitted>October 16, 2019</last_update_submitted>
  <last_update_submitted_qc>October 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 23, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT02451670/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All patients with an adult primary care visit with a primary care provider in a randomized clinic were assessed for study eligibility. After entry of blood pressure data, relevant health record data were automatically extracted, encrypted and processed through Web-based clinical algorithms that determined eligibility.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Prioritized Clinical Support</title>
          <description>Patients and their primary care providers in the intervention arm were presented with patient-specific written advice as to prioritized treatment and lifestyle changes that could reduce their cardiovascular risk, prompted by an electronic health record-based alert during their primary care visit.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Patients and their primary care providers in the usual care arm were not presented with prioritized clinical decision support.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5264"/>
                <participants group_id="P2" count="5083"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4550"/>
                <participants group_id="P2" count="4387"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="714"/>
                <participants group_id="P2" count="696"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not have qualifying follow-up visit.</title>
              <participants_list>
                <participants group_id="P1" count="714"/>
                <participants group_id="P2" count="696"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Patients whose data was included in the baseline analysis population met eligibility criteria, had an index visit at a randomized clinic at which they were eligible for the CV Wizard intervention, and had at least one follow-up visit in a randomized primary care clinic.</population>
      <group_list>
        <group group_id="B1">
          <title>Prioritized Clinical Decision Support</title>
          <description>Patients and their primary care providers were presented with patient-specific written instructions as to prioritized treatment and lifestyle changes that could reduce cardiovascular risk, prompted by an electronic health record-based alert during their primary care visits.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Patients and their providers were not presented with the prioritized clinical decision support.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4550"/>
            <count group_id="B2" value="4387"/>
            <count group_id="B3" value="8937"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.6" spread="13.3"/>
                    <measurement group_id="B2" value="48.1" spread="13.4"/>
                    <measurement group_id="B3" value="48.4" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2530"/>
                    <measurement group_id="B2" value="2393"/>
                    <measurement group_id="B3" value="4923"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2020"/>
                    <measurement group_id="B2" value="1994"/>
                    <measurement group_id="B3" value="4014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="108"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4508"/>
                    <measurement group_id="B2" value="4321"/>
                    <measurement group_id="B3" value="8829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="113"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="517"/>
                    <measurement group_id="B2" value="390"/>
                    <measurement group_id="B3" value="907"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3749"/>
                    <measurement group_id="B2" value="3741"/>
                    <measurement group_id="B3" value="7490"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                    <measurement group_id="B2" value="129"/>
                    <measurement group_id="B3" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4550"/>
                    <measurement group_id="B2" value="4387"/>
                    <measurement group_id="B3" value="8937"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124.4" spread="16.6"/>
                    <measurement group_id="B2" value="124.2" spread="16.5"/>
                    <measurement group_id="B3" value="124.3" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78.3" spread="11.4"/>
                    <measurement group_id="B2" value="78.3" spread="11.4"/>
                    <measurement group_id="B3" value="78.3" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Active Smoker</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4550"/>
                    <count group_id="B2" value="4387"/>
                    <count group_id="B3" value="8937"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2131"/>
                    <measurement group_id="B2" value="2027"/>
                    <measurement group_id="B3" value="4158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Aspirin Use</title>
          <population>Only patients that met criteria for aspirin therapy were included in this measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="907"/>
                    <count group_id="B2" value="822"/>
                    <count group_id="B3" value="1729"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="519"/>
                    <measurement group_id="B2" value="461"/>
                    <measurement group_id="B3" value="980"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Low-Density Lipoprotein Cholesterol</title>
          <population>Only patients that had a recent Low-Density Lipoprotein result in their electronic medical record were included in this measure.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3680"/>
                    <count group_id="B2" value="3536"/>
                    <count group_id="B3" value="7216"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104.9" spread="35.4"/>
                    <measurement group_id="B2" value="104.6" spread="35.6"/>
                    <measurement group_id="B3" value="104.8" spread="7978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <population>Only patients with a recent weight in their electronic medical record were included in this measure.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="4135"/>
                    <count group_id="B2" value="3943"/>
                    <count group_id="B3" value="8078"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.5" spread="7.8"/>
                    <measurement group_id="B2" value="32.7" spread="7.9"/>
                    <measurement group_id="B3" value="32.6" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke</title>
        <description>A modifiable risk component for each cardiovascular risk factor not at optimal goal at the time of each encounter was calculated as the difference between total 10-year atherosclerotic cardiovascular disease risk with the patient's actual values and the goal value. Total modifiable cardiovascular risk was calculated by summing the modifiable cardiovascula risk components across cardiovascular risk factors not at optimal goal at the time of the encounter, and was calculated for each enrolled patient at the index visit and each subsequent encounter during the intervention period. Annual rate of change in modifiable cardiovascular risk was estimated from all patient encounters. A comparison of the difference in model-estimated rate of change in modifiable cardiovascular risk at 12 months post-index tested the primary efficacy hypothesis.</description>
        <time_frame>Index to 12 months post index visit</time_frame>
        <population>The patients whose data were included in the primary outcome analysis met eligibility criteria, had an index visit at a randomized clinic at which they were eligible for the Cardiovascular Wizard intervention, and had at least one follow-up visit in a randomized primary care clinic.</population>
        <group_list>
          <group group_id="O1">
            <title>Prioritized Clinical Decision Support</title>
            <description>Patients and their primary care providers were presented with their patient-specific written advice as to prioritized treatment and lifestyle changes that could reduce their cardiovascular risk, prompted by an electronic health record based alert during their primary care visits.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Patients and providers were not presented with the prioritized clinical decision support.</description>
          </group>
        </group_list>
        <measure>
          <title>Predicted Annual Rate of Change in 10 Year Risk of Fatal or Nonfatal Heart Attack or Stroke</title>
          <description>A modifiable risk component for each cardiovascular risk factor not at optimal goal at the time of each encounter was calculated as the difference between total 10-year atherosclerotic cardiovascular disease risk with the patient's actual values and the goal value. Total modifiable cardiovascular risk was calculated by summing the modifiable cardiovascula risk components across cardiovascular risk factors not at optimal goal at the time of the encounter, and was calculated for each enrolled patient at the index visit and each subsequent encounter during the intervention period. Annual rate of change in modifiable cardiovascular risk was estimated from all patient encounters. A comparison of the difference in model-estimated rate of change in modifiable cardiovascular risk at 12 months post-index tested the primary efficacy hypothesis.</description>
          <population>The patients whose data were included in the primary outcome analysis met eligibility criteria, had an index visit at a randomized clinic at which they were eligible for the Cardiovascular Wizard intervention, and had at least one follow-up visit in a randomized primary care clinic.</population>
          <units>percentage of annual rate of change</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4550"/>
                <count group_id="O2" value="4387"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2"/>
                    <measurement group_id="O2" value="20.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse event data was collected on the date of the after-index visit and every subsequent visit through the end of the intervention period on September 19, 2018.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Prioritized Clinical Decision Support</title>
          <description>Patients and providers were presented with patient-specific written advice as to prioritized treatment and lifestyle changes that could reduce their cardiovascular risk, prompted by an electronic health record based alert during their primary care visits.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Patients and providers were not presented with the prioritized clinical decision support.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="526" subjects_at_risk="4550"/>
                <counts group_id="E2" subjects_affected="581" subjects_at_risk="4837"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="722" subjects_at_risk="4550"/>
                <counts group_id="E2" subjects_affected="763" subjects_at_risk="4387"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>In Patient Hospitalization</sub_title>
                <counts group_id="E1" events="1331" subjects_affected="702" subjects_at_risk="4550"/>
                <counts group_id="E2" events="1415" subjects_affected="734" subjects_at_risk="4387"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" events="126" subjects_affected="80" subjects_at_risk="4550"/>
                <counts group_id="E2" events="170" subjects_affected="118" subjects_at_risk="4387"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1593" subjects_at_risk="4550"/>
                <counts group_id="E2" subjects_affected="1882" subjects_at_risk="4387"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Emergency Room Visit</sub_title>
                <counts group_id="E1" events="5373" subjects_affected="1593" subjects_at_risk="4550"/>
                <counts group_id="E2" events="6863" subjects_affected="1882" subjects_at_risk="4387"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Because the study was conducted in three large medical groups in the same area of the country, generalizability of results to other care systems or populations is uncertain.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Rebecca Rossom</name_or_title>
      <organization>HealthPartnersInstitute</organization>
      <phone>952-883-5466</phone>
      <email>Rebecca.C.Rossom@HealthPartners.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

